Status:
COMPLETED
Prognostic Factors on Malignant Pleural Effusion
Lead Sponsor:
The University of Hong Kong
Conditions:
Pleural Effusion, Malignant
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Malignant pleural effusion can occur in up to half of the patients with metastatic disease. It can cause shortness of breath to patients and so far there is no protocol on its management. The study i...
Detailed Description
Malignant pleural effusion (MPE) is common, and is estimated to affect up to a half of patients with malignancy, either at the time or during subsequent clinical course after the diagnosis of malignan...
Eligibility Criteria
Inclusion
- malignant pleural effusion (MPE) due to lung cancer
Exclusion
- workup of MPE (pleural fluid results, blood test results, or treatment history) not available
- Patients unwilling to join study (for prospective recruitment)
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
233 Patients enrolled
Trial Details
Trial ID
NCT03276715
Start Date
June 1 2016
End Date
October 1 2018
Last Update
October 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong